Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ann Surg. 2019 Oct;270(4):639–646. doi: 10.1097/SLA.0000000000003484

Figure 3.

Figure 3.

Panel A: Incompatible program participants by race and sex; Panel B: Proportion of LDKT recipients in the incompatible LDKT program with history of sensitizing events, by race and sex; Panel C: Calculated panel reactive antibody (cPRA) distribution among incompatible program LDKT recipients by race and sex.